Transdiagnostic cognitive-behavioral therapy

BEHAVIORAL2 trials

Sponsors

Université de Sherbrooke, University of Oviedo

Conditions

Addictive BehaviorsAgoraphobiaEmotion RegulationGeneralized Anxiety DisorderPanic DisorderSocial Anxiety Disorder

Unknown Phase

Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders

CompletedNCT02811458

Université de SherbrookeAgoraphobia, Generalized Anxiety Disorder, Panic Disorder +1

Start: 2016-09-12End: 2019-07-10Updated: 2019-09-17

A Novel Adaptation of the Unified Protocol (UP) as a Transdiagnostic Intervention for Emotional Disorders in Addictive Behaviors

Enrolling by invitationNCT07738081

University of OviedoAddictive Behaviors, Emotion Regulation

Start: 2026-01-05End: 2026-10-31Target: 60Updated: 2026-07-30

Related Papers

Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework

BMC Health Services Research2023-06-081 citations

A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.

2018-10-0310 citations